Stay updated with breaking news from Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) shares reached a new 52-week high on Monday . The company traded as high as $10.98 and last traded at $10.86, with a volume of 44021 shares trading hands. The stock had previously closed at $10.53. Wall Street Analyst Weigh In A number of research analysts recently […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 1,150,000 shares, an increase of 8.5% from the April 30th total of 1,060,000 shares. Based on an average daily volume of 107,200 shares, the short-interest ratio is presently 10.7 […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,150,000 shares, a growth of 8.5% from the April 30th total of 1,060,000 shares. Based on an average daily volume of 107,200 shares, the days-to-cover ratio […]
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present... | May 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company